← Leaderboards
Jeffrey L Staudinger
University Of Kansas Lawrence
$3,061,121
Attributed
$3,271,121
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $429.4K · FY2005–24$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,271,121 · 5
By mechanism
R01$2,562,175 · 2
R15$420,000 · 1
P20$288,946 · 2
Top collaborators
- Bradley Allen Creamer1 shared
Most similar at University Of Kansas Lawrence
Same institution · by research overlap
- Zijun Wang$2,409,832
- Gonzalo Andres Carrasco$146,666
Others in their field
Top investigators on “Xenobiotics”
- Wen Xie · University Of Pittsburgh At Pittsburgh$18,748,524
- Eric F Johnson · Scripps Research Institute$17,523,123
- Garret A Fitzgerald · University Of Pennsylvania$15,798,174
- Maria Almira Correia · University Of California San Francisco$14,407,902
- Kenneth Michael Pollard · Scripps Research Institute, The$12,740,073
- W. Ian Lipkin · University Of California Irvine$12,732,649
Research focus
XenobioticsMediatingGene TargetingNuclear ReceptorsLiverResponseIntestinesGenesPharmaceutical PreparationsPromotor (Genetics)InsightInflammatory ResponseLiver DiseasesLigandsProteinsBiochemicalInflammationCytokineMolecularCarrier ProteinsBaseHepaticInflammatoryPrevent
Grant awards (13)
Investigating the Roles of Pregnane X Receptor in Human Breast Cancers$420,000
R15 · FY2024 · CA
Inflammation, PXR Modification and Drug Disposition$315,780
R01 · FY2014 · DK · contact PI
Inflammation, PXR Modification and Drug Disposition$305,010
R01 · FY2013 · DK · contact PI
Inflammation, PXR Modification and Drug Disposition$316,340
R01 · FY2012 · DK · contact PI
Inflammation, PXR Modification and Drug Disposition$363,892
R01 · FY2011 · DK · contact PI
Cell Signaling, PXR Phosphorylation & Drug Disposition$244,790
R01 · FY2009 · DK · contact PI
Cell Signaling, PXR Phosphorylation & Drug Disposition$244,878
R01 · FY2008 · DK · contact PI
Cell Signaling, PXR Phosphorylation & Drug Disposition$249,963
R01 · FY2007 · DK · contact PI
Cell Signaling, PXR Phosphorylation & Drug Disposition$257,537
R01 · FY2006 · DK · contact PI
Cell Signaling, PXR Phosphorylation &Drug Disposition$263,985
R01 · FY2005 · DK
COBRE: U KS: P5: CRYSTALLIZATION OF PREGNANE X RECEPTOR SPLICE VARIANTS$165,429
P20 · FY2005 · RR
COBRE: U KS: P5: CRYSTALLIZATION OF PREGNANE X RECEPTOR SPLICE VARIANTS$123,517
P20 · FY2004 · RR
Crystallization of pregnane X receptor splice variants$0
P20 · FY2002 · RR